Kanoun, R. Y.; Abdeljelil, N. B.; Mekni, S.; Kasdallah, M.; Ouerghi, R.; Ben Yaiche, I.; Torjemane, L.; Belloumi, D.; Turki, I.; Safra, I. Role of Measurable Residual Disease Quantified by 4 to 6 Color Flow Cytometry before Allogeneic Hematopoietic Stem Cell Transplantation for High-Risk Philadelphia-Negative Acute Lymphoblastic Leukemia. J Stem Cell Ther Transplant 2023, 7, 016-023.